Position in VTRS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$471,286
+$469,990 QoQ
Shares Held
29,678
+30814.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#422
of 1,020 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PICTON MAHONEY ASSET MANAGEMENT holds $70,030,747 across 11 Drug Manufacturers - Specialty & Generic names. VTRS ranks #7 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
925,408 | $31,352,823 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
979,269 | $24,099,810 | |
| 3 | TRLV |
Trulieve Cannabis Corp.
|
838,088 | $8,238,405 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
112,616 | $3,904,396 | |
| 5 | BHC |
Bausch Health Companies Inc.
|
299,232 | $1,475,213 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
2,809 | $473,428 | |
| 7 | VTRS |
Viatris Inc
This page
|
29,678 | $471,286 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
402 | $6,958 |
All Filings in VTRS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $471,286 | 29,678 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,296 | 96 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,195 | 96 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $950 | 96 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1 | 96 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1 | 96 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1 | 96 | Shares | Sole | 2025-04-02 | |
| 2024-09-30 | $1 | 96 | Shares | Sole | 2024-11-04 | |
| No filing history on record for this holder in this stock. | ||||||